SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-24-024983
Filing Date
2024-03-22
Accepted
2024-03-22 10:24:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0202342-424b5_nlspharma.htm 424B5 392874
2 GRAPHIC image_001.jpg GRAPHIC 14060
  Complete submission text file 0001213900-24-024983.txt   413389
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262489 | Film No.: 24773596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)